Clinical trial
Long Term Effect of AIT in Children
Name
HCA-AIT
Description
The present study will investigate the long term effect of allergen immunotherapy in a real-life study in children with allergy undergoing subcutaneous or sublingual immunotherapy with grass pollen, birch, house dust mites or venom.
Trial arms
Trial start
2024-05-01
Estimated PCD
2036-12-01
Trial end
2037-05-01
Status
Recruiting
Treatment
Allergen Immunotherapy Extract
Patients will be treated as usual. The study is an observation of the long term effect of the treatment
Size
100
Primary endpoint
Effect of immunotherapy 5 years after end of treatment
5 years
Eligibility criteria
Inclusion Criteria: treated with allergen immunotherapy at HCA Children'sHospital, Odense University Hospital -
Exclusion Criteria: received less than 12 months of treatment with allergen immunotherapy
-
Protocol
{'studyType': 'OBSERVATIONAL', 'patientRegistry': True, 'targetDuration': '14 Years', 'designInfo': {'observationalModel': 'COHORT', 'timePerspective': 'PROSPECTIVE'}, 'enrollmentInfo': {'count': 100, 'type': 'ESTIMATED'}}
Updated at
2024-05-28
1 organization
1 product
1 indication
Organization
Odense University HospitalIndication
Allergies in Children